Crohn's Disease: A Study to Evaluate the Efficacy and Safety of Certolizumab Pegol for Induction of Remission

07/2/2009

Alabama, Colorado, Florida, Illinois, Kentucky, Louisiana, Maryland, Michigan, Minnesota, North Carolina, Ohio, Oklahoma, Pennsylvania, Tennessee, Virginia, Washington; Australia, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Estonia, Finland, Germany, Hungary, Israel, Italy, Latvia, New Zealand, Poland, Romania, Russian Federation, Ukraine. clinicaltrials.gov

Published in Brief:

SmartBrief Job Listings for Health Care